Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06316973 · ClinicalTrials.gov registry record · Phase 1
A Clinical Study to Evaluate the Safety of CS-1103 in Healthy Participants
A Phase 1 study, sponsored by Clear Scientific.
- Completed
- Registry status
- Phase 1
- Development phase
- 32
- Enrollment target
NCT06316973 is a Phase 1 study that has completed, run by Clear Scientific. The registered enrollment target is 32 participants.
The verdict
NCT06316973, a Phase 1 study, has completed, sponsored by Clear Scientific.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 32 participants
- Enrollment target
Study Summary
The purpose of this Phase 1a study is to evaluate safety, tolerability, and pharmacokinetics (PK) of single, ascending doses of CS-1103, administered by intravenous (IV) infusion in healthy participants.
Interventions
- DRUG Sterile Saline
- DRUG CS-1103
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2024-02-07 |
| Est. Completion | 2024-06-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06316973
The ClinicalTrials.gov registry entry for NCT06316973 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Clear Scientific, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sterile Saline is the first listed.
NCT06316973 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06316973 about?
NCT06316973 is a clinical study titled "A Clinical Study to Evaluate the Safety of CS-1103 in Healthy Participants". The purpose of this Phase 1a study is to evaluate safety, tolerability, and pharmacokinetics (PK) of single, ascending doses of CS-1103, administered by intravenous (IV) infusion in healthy participants.
What is the current status of trial NCT06316973?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 32 participants. The study started on 2024-02-07. Estimated completion is 2024-06-06.
What interventions are being tested in trial NCT06316973?
The interventions under investigation include: Sterile Saline (DRUG), CS-1103 (DRUG).
Who is sponsoring clinical trial NCT06316973?
This trial is sponsored by Clear Scientific, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.